Atea Pharmaceuticals Inc. (AVIR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Atea Pharmaceuticals Inc.

    NASDAQ: AVIR · Real-Time Price · USD
    2.92
    -0.01 (-0.34%)
    At close: Sep 29, 2025, 2:46 PM

    Atea Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a 351.37M
    Cost of Revenue
    		 416K 70.09M 260K 29K
    Gross Profit
    		 -416K -70.09M -260K 351.34M
    Operating Income
    		 -192.95M -164.16M -130.65M 138.38M
    Interest Income
    		 25.49M 29.22M 11.15M 213K
    Pretax Income
    		 -167.46M -134.94M -119.5M 138.59M
    Net Income
    		 -168.38M -135.96M -115.91M 121.19M
    Selling & General & Admin
    		 48.85M 49.92M 48.71M 45.78M
    Research & Development
    		 144.1M 132.84M 81.94M 167.21M
    Other Expenses
    		 n/a -88.69M n/a n/a
    Operating Expenses
    		 192.95M 94.07M 130.65M 212.99M
    Interest Expense
    		 n/a n/a 11.15M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 192.95M 164.16M 130.65M 212.99M
    Income Tax Expense
    		 925K 1.02M -3.59M 17.4M
    Shares Outstanding (Basic)
    		 84.26M 83.39M 83.25M 82.82M
    Shares Outstanding (Diluted)
    		 84.26M 83.39M 83.25M 88.25M
    EPS (Basic)
    		 -2 -1.63 -1.39 1.46
    EPS (Diluted)
    		 -2 -1.63 -1.39 1.37
    EBITDA
    		 -167.04M -119.59M -119.24M 138.41M
    EBIT
    		 -167.46M -120.01M -119.5M 138.38M
    Depreciation & Amortization
    		 416K 416K 260K 29K

    Add to Watchlist